Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery

被引:41
作者
Han, Ri [1 ]
Yoon, Hongryul [1 ]
Kim, Gahee [1 ]
Lee, Hyundo [1 ]
Lee, Yoonji [1 ]
机构
[1] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea
基金
新加坡国家研究基金会;
关键词
artificial intelligence; drug discovery; medicinal chemistry; structure-based drug design; INDUCED LIVER-INJURY; PROTEIN INTERACTION PREDICTION; VARIATIONAL AUTOENCODERS; MECHANISTIC ANALYSIS; INTERACTION NETWORKS; POTASSIUM CHANNEL; COMPOUND ACTIVITY; NEURAL-NETWORK; TARGET; FINGERPRINTS;
D O I
10.3390/ph16091259
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Artificial intelligence (AI) has permeated various sectors, including the pharmaceutical industry and research, where it has been utilized to efficiently identify new chemical entities with desirable properties. The application of AI algorithms to drug discovery presents both remarkable opportunities and challenges. This review article focuses on the transformative role of AI in medicinal chemistry. We delve into the applications of machine learning and deep learning techniques in drug screening and design, discussing their potential to expedite the early drug discovery process. In particular, we provide a comprehensive overview of the use of AI algorithms in predicting protein structures, drug-target interactions, and molecular properties such as drug toxicity. While AI has accelerated the drug discovery process, data quality issues and technological constraints remain challenges. Nonetheless, new relationships and methods have been unveiled, demonstrating AI's expanding potential in predicting and understanding drug interactions and properties. For its full potential to be realized, interdisciplinary collaboration is essential. This review underscores AI's growing influence on the future trajectory of medicinal chemistry and stresses the importance of ongoing synergies between computational and domain experts.
引用
收藏
页数:34
相关论文
共 244 条
  • [1] 3ds, Registry of Toxic Effects of Chemical Substances (RTECS)
  • [2] accessdata fda, Drugs@FDA: FDA-Approved Drugs
  • [3] Predicting Drug-Induced Liver Injury Using Ensemble Learning Methods and Molecular Fingerprints
    Ai, Haixin
    Chen, Wen
    Zhang, Li
    Huang, Liangchao
    Yin, Zimo
    Hu, Huan
    Zhao, Qi
    Zhao, Jian
    Liu, Hongsheng
    [J]. TOXICOLOGICAL SCIENCES, 2018, 165 (01) : 100 - 107
  • [4] Drug Metabolism in the Liver
    Almazroo, Omar Abdulhameed
    Miah, Mohammad Kowser
    Venkataramanan, Raman
    [J]. CLINICS IN LIVER DISEASE, 2017, 21 (01) : 1 - +
  • [5] Exploring Chemical Reaction Space with Reaction Difference Fingerprints and Parametric t-SNE
    Andronov, Mikhail
    Fedorov, Maxim, V
    Sosnin, Sergey
    [J]. ACS OMEGA, 2021, 6 (45): : 30743 - 30751
  • [6] In Silico ADME/Tox Profiling of Natural Products: A Focus on BIOFACQUIM
    Angeles Duran-Iturbide, Noemi
    Diaz-Eufracio, Barbara, I
    Medina-Franco, Jose L.
    [J]. ACS OMEGA, 2020, 5 (26): : 16076 - 16084
  • [7] Protein tertiary structure prediction and refinement using deep learning and Rosetta in CASP14
    Anishchenko, Ivan
    Baek, Minkyung
    Park, Hahnbeom
    Hiranuma, Naozumi
    Kim, David E.
    Dauparas, Justas
    Mansoor, Sanaa
    Humphreys, Ian R.
    Baker, David
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2021, 89 (12) : 1722 - 1733
  • [8] Drug-Target Interactions: Prediction Methods and Applications
    Anusuya, Shanmugam
    Kesherwani, Manish
    Priya, K. Vishnu
    Vimala, Antonydhason
    Shanmugam, Gnanendra
    Velmurugan, Devadasan
    Gromiha, M. Michael
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2018, 19 (06) : 537 - 561
  • [9] Arabi A. A., 2021, FUTURE DRUG DISCOV, V3, DOI [10.4155/fdd-2020-0028, DOI 10.4155/FDD-2020-0028]
  • [10] DrugCentral 2023 extends human clinical data and integrates veterinary drugs
    Avram, Sorin
    Wilson, Thomas B.
    Curpan, Ramona
    Halip, Liliana
    Borota, Ana
    Bora, Alina
    Bologa, Cristian G.
    Holmes, Jayme
    Knockel, Jeffrey
    Yang, Jeremy J.
    Oprea, Tudor, I
    [J]. NUCLEIC ACIDS RESEARCH, 2023, 51 (D1) : D1276 - D1287